Press release
Rising Alzheimer's Cases Propel Growth Of The Market Driver: Leading Transformation in the Donepezil Market in 2025
Donepezil
The increasing prevalence of Alzheimer's disease is expected to propel the growth of the donepezil market. Alzheimer's disease, a progressive neurological disorder, is becoming more prevalent due to factors like an aging population, lifestyle changes, and genetic predispositions. Donepezil is a well-known treatment that helps manage symptoms of Alzheimer's by improving cognitive function. As the number of individuals diagnosed with Alzheimer's continues to rise-the Alzheimer's Association reports an increase from 6.5 million to 6.9 million cases in the U.S. alone by 2024-the demand for medications like donepezil will continue to grow, driving market expansion.
Get Your Donepezil Market Report Here:
https://www.thebusinessresearchcompany.com/report/donepezil-global-market-report
What is the projected compound annual growth rate (CAGR) of the donepezil market from 2025 to 2034, and what factors influence it?
The donepezil market has grown steadily, increasing from $1.00 billion in 2024 to $1.05 billion in 2025 at a CAGR of 5.1%. Historical growth has been driven by the increasing prevalence of Alzheimer's disease, a growing geriatric population, rising government spending and programs, greater awareness of neurodegenerative disorders, and rising demand for high-quality nucleic acid samples.
The donepezil market is projected to see steady growth, reaching $1.27 billion by 2029 with a CAGR of 4.9%. Growth factors include rising healthcare expenditures, increasing efforts to diagnose Alzheimer's at earlier stages, growing demand for combination therapies, larger investments in healthcare infrastructure, and greater awareness of neurodegenerative diseases. Industry trends include innovations in drug formulations and delivery methods, technological advancements, the introduction of novel dosage forms and formulations, approvals of generic donepezil versions, and the expansion of advanced research facilities.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21174&type=smp
How are the latest trends influencing the growth of the donepezil market?
In the donepezil market, companies are innovating with advanced drug delivery systems such as the donepezil transdermal system to improve patient compliance and treatment effectiveness. For instance, in October 2022, Corium Innovation Inc., a US-based biopharmaceutical company, launched the Adlarity transdermal system to treat Alzheimer's disease. This new formulation delivers donepezil through the skin, bypassing the digestive system and reducing the likelihood of gastrointestinal side effects, offering a more convenient and effective treatment option for Alzheimer's patients and their caregivers.
What are the major segments of the donepezil market and their role in driving growth?
The donepezil market covered in this report is segmented -
1) By Type: 5mg, 10mg, 23mg
2) By Route Of Administration: Oral, Transdermal
3) By Application: Hospitals, Clinics, Drugstore
Subsegments:
1) By 5mg: Immediate-Release 5mg, Orally Disintegrating 5mg
2) By 10mg: Immediate-Release 10mg, Orally Disintegrating 10mg
3) By 23mg: Extended-Release 23mg, Film-Coated 23mg
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21174
Which regions are key players in the growth of the donepezil market?
North America was the largest region in the donepezil market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the donepezil market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the key firms paving the way for growth in the donepezil market?
Major companies operating in the donepezil market are AbbVie Inc., Pfizer Inc., Teva Pharmaceutical Inc., Intas Pharmaceuticals Ltd., Mylan NV, Sandoz Group AG, Hetero Drugs Ltd., Sun Pharmaceutical Inc., Eisai Co. Ltd., Cipla Ltd., Dr Reddy's Laboratories, Apotex Inc., H Lundbeck A/S, Zydus Cadila, Amneal Pharmaceuticals LLC, Torrent Pharmaceuticals Ltd, Alkem Laboratories Ltd., Jubilant Pharmova Ltd., Wockhardt Ltd., Luoxin Pharmaceuticals Group
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21174&type=smp
What Is Covered In The Donepezil Global Market Report?
•Market Size Forecast: Examine the donepezil market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the donepezil market for a structured understanding.
•Key Players Overview: Analyze major players in the donepezil market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the donepezil market.
•Segment Contributions: Evaluate how different segments drive overall growth in the donepezil market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the donepezil market.
•Industry Challenges: Identify potential risks and obstacles affecting the donepezil market.
•Competitive Landscape: Review strategic developments in the donepezil market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Alzheimer's Cases Propel Growth Of The Market Driver: Leading Transformation in the Donepezil Market in 2025 here
News-ID: 3936923 • Views: …
More Releases from The Business Research Company
Growing Aircraft Demand Propels Defense Navigation Market: An Emerging Driver Tr …
The Defense Navigation Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Defense Navigation Market?
The Defense Navigation Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores…
Cyberknife Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportun …
The Cyberknife Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Cyberknife Market?
The Cyberknife Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends,…
Crohn's Disease Treatment Market Size Projected To Reach $17.67 Billion By 2034 …
The Crohn's Disease Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Crohn's Disease Treatment Market?
The Crohn's Disease Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034.…
Contraband Detector Market Forecast 2025-2034: Comprehensive Analysis And Growth …
The Contraband Detector Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Contraband Detector Market?
The Contraband Detector Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores…
More Releases for Alzheimer
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
Anti-β-Alzheimer Therapies Market : Consumption, Revenue, Applications With Maj …
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer…
Anti-β-Alzheimer Therapies That Cut Attacks Hailed As 'huge Deal'
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer…
Alzheimer Diagnostic Tests Market - Medical Devices Pipeline Assessment, 2017 | …
"The Latest Research Report Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
About Alzheimer Diagnostic Tests Market
GlobalData's Medical Devices sector report, Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports.
Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as…
